M. Muraki et al., THE EFFECT OF TYB-2285 ON DUAL-PHASE BRONCHOCONSTRICTION AND AIRWAY HYPERSENSITIVITY IN GUINEA-PIGS ACTIVELY SENSITIZED WITH OVALBUMIN, Journal of Pharmacy and Pharmacology, 46(11), 1994, pp. 883-886
The effect of a new anti-asthmatic drug, TYB-2285 3,5-bis(acetoxyacety
lamino)-4-chlorobenzonitrile), was investigated in ovalbumin-sensitize
d guinea-pigs. When guinea-pigs were pretreated with TYB-2285 (300 mg
kg(-1), p.o., single dose or consecutively for 7 days), the immediate
asthmatic response was inhibited as demonstrated by diminished cyanosi
s, but not the bronchoconstriction. TYB-2285, given singly or consecut
ively, inhibited the appearance of late asthmatic response and the inf
iltration of inflammatory cells, such as eosinophils, into the airway.
Additionally, airway hyper-responsiveness was also reversed by the si
ngle administration of TYB-2285. Luminol-dependent chemiluminescence o
f airway-infiltrated cells stimulated with A23187 was inhibited by TYB
-2285 in a dose-dependent manner. The present study suggests that TYB-
2285 inhibits late asthmatic response and airway hyperresponsiveness b
y inhibiting the accumulation of eosinophils and other inflammatory ce
lls into the airway, and also by inhibiting the production of oxygen r
adicals from airway-infiltrated cells.